US2017348347A1PendingUtilityA1

Agent for improving ocular subjective symptoms and method thereof

56
Assignee: SEIKAGAKU KOGYO CO LTDPriority: Dec 26, 2014Filed: Dec 25, 2015Published: Dec 7, 2017
Est. expiryDec 26, 2034(~8.4 yrs left)· nominal 20-yr term from priority
Inventors:Masamichi YamadaChiyo SakenagaKeiichiro Arai
A61K 9/08A61K 9/0048A61P 27/04A61K 31/728A61P 27/02
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided is an agent for improving human ocular subjective symptoms containing hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto.

Claims

exact text as granted — not AI-modified
1 . An agent for improving human ocular subjective symptoms comprising hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto. 
     
     
         2 . The agent according to  claim 1 , wherein the agent is in the form of a solution and the hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto is contained at a concentration of 0.3% (w/v). 
     
     
         3 . The agent according to  claim 1 , wherein the human is a person with dry eye. 
     
     
         4 . A method for improving human ocular subjective symptoms comprising a step for administering hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto to a human eye. 
     
     
         5 . The method according to  claim 4 , wherein the hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto is administered in the form of a solution having a concentration of 0.3% (w/v). 
     
     
         6 . The method according to  claim 4 , wherein the human is a person with dry eye. 
     
     
         7 . A use of hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto for improving human ocular subjective symptoms. 
     
     
         8 . The use according to  claim 7 , wherein the hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto is administered in the form of a solution having a concentration of 0.3% (w/v). 
     
     
         9 . The use according to  claim 7 , wherein the human is a person with dry eye.

Join the waitlist — get patent alerts

Track US2017348347A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.